Eulexin Related Clinical Trials
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer [Recruiting]
Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer [Recruiting]
Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric Disorder [Recruiting]
Metabolic Syndrome in PCOS: Precursors and Interventions [Recruiting]
Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome [Recruiting]
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer [Completed]
Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate [Completed]
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Recruiting]
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia [Active, not recruiting]
Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome [Recruiting]
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone [Recruiting]
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma [Completed]
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer [Completed]
To Lengthen the Duration of the Off-Treatment of Intermittent Androgen Suppression [Active, not recruiting]
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer [Recruiting]
Hormone Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer [Active, not recruiting]
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer [Recruiting]
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer [Active, not recruiting]
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer [Recruiting]
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer [Completed]
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer [Completed]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Recruiting]
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Recruiting]
Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer [Recruiting]
Intermittent Hormone Therapy in Men With Localized Prostate Cancer After Radiation Therapy or Radical Prostatectomy [Recruiting]
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer [Active, not recruiting]
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer [Completed]
Hormone Therapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [Withdrawn]
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer [Active, not recruiting]
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer [Completed]
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy [Recruiting]
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy [Recruiting]
Erectile Dysfunction/Prostate/RT/Androgen [Completed]
An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate [Recruiting]
|
